Business, energy, technology, markets and global industry news from Business News Today

Medical Devices & Diagnostics

PharmaDeviceNews Medical Devices & Diagnostics
Bruker launches MyGenius PRO at ESCMID 2026 to scale transplant-focused molecular diagnostics
Medical Devices & Diagnostics

Why MyGenius PRO could strengthen Bruker’s position in automated infectious disease diagnostics

Bruker Corporation has launched MyGenius PRO, a high-throughput sample-to-answer molecular diagnostics system, at ESCMID Global 2026 in Europe. The platform enters the infectious disease diagnostics market with IVDR assays for Cytomegalovirus, Epstein-Barr virus, and BK virus, positioning it squarely in transplant and immunocompromised patient testing where automation, turnaround time, and workflow reliability matter commercially as

Read More
Representative image of a laboratory researcher reviewing spatial proteomics data for early-stage breast cancer, reflecting the clinical oncology focus behind the AidaBREAST assay and its potential role in recurrence risk and radiation therapy benefit assessment.
Medical Devices & Diagnostics

Can PreludeDx and Quanterix turn AidaBREAST into a new standard for radiation therapy decisions

See why AidaBREAST could reshape breast cancer radiation decisions and put spatial proteomics closer to routine oncology use.

Read More
Representative image of a cancer research laboratory and DNA damage analysis, illustrating the translational science behind intoDNA’s sSTRIDE-NER and sSTRIDE-PARP1 assay presentations at AACR 2026.
Medical Devices & Diagnostics

IntoDNA unveils sSTRIDE-NER and sSTRIDE-PARP1 at AACR 2026, can functional DNA repair assays reshape precision oncology?

IntoDNA revealed two novel DNA repair assays at AACR 2026. Read why sSTRIDE-NER and sSTRIDE-PARP1 could matter for oncology biomarker research.

Read More
Representative image of blood-based ctDNA testing and molecular residual disease monitoring, reflecting the AACR 2026 focus on SAGA Diagnostics’ Pathlight platform in metastatic breast cancer and ovarian cancer.
Medical Devices & Diagnostics

AACR 2026: SAGA Diagnostics pushes Pathlight MRD deeper into metastatic breast and ovarian cancer

Read how SAGA Diagnostics’ AACR 2026 Pathlight data could reshape ctDNA monitoring in metastatic breast and ovarian cancer.

Read More
SurGenTec’s TiLink SI joint fusion clearance shows why procedural ecosystems now matter as much as implants
Medical Devices & Diagnostics

What SurGenTec’s TiLink navigation clearance means for surgeons using minimally invasive SI joint fusion systems

SurGenTec won FDA 510(k) clearance for TiLink navigation instruments. Read what this means for SI joint fusion adoption, workflow, and competition.

Read More
Medical Devices & Diagnostics

Can Covalon Technologies convert IV contamination education into adoption of VALGuard and CovaClear?

Covalon Technologies is gaining momentum in vascular access and wound care. Read why its latest milestones could shape medtech growth next.

Read More
Medical Devices & Diagnostics

CareDx divests Lab Products for $170m as core transplant diagnostics gains momentum

CareDx is selling its Lab Products business for $170 million. Read what the deal means for transplant diagnostics, growth focus, and execution risk.

Read More
Representative image of cataract surgery with an intraocular lens, used to illustrate Johnson & Johnson’s TECNIS PureSee data at ASCRS 2026 and the shifting premium IOL market.
Medical Devices & Diagnostics

Can TECNIS PureSee help Johnson & Johnson win the next phase of premium cataract surgery?

Johnson & Johnson’s TECNIS PureSee data could reshape premium cataract surgery. Read what the ASCRS 2026 findings may change next.

Read More
Medical Devices & Diagnostics

Plus Therapeutics reimbursement push gains traction as AMA grants CNSide a dedicated PLA code

Plus Therapeutics has won an AMA PLA code for CNSide. Read why this reimbursement milestone could shape adoption, coverage, and diagnostic growth.

Read More
Miracell FDA clearance opens new test for SMART M-CELL in regenerative medicine
Medical Devices & Diagnostics

Why Miracell’s SMART M-CELL FDA clearance could reshape the PRP and BMAC device market

Miracell has won FDA 510(k) clearance for SMART M-CELL. Read what it changes for PRP, BMAC, adoption, and regenerative medicine competition.

Read More